US$ 21.57
is wegovy a glp-1 drug weight-loss drugs: PA, NJ poison control centers see more calls Key Lessons for Ethical and
Description
FTI Consultings survey shows that more than 20 percent of US adults have used them in the past 12 months, despite high costs, side effects and the need for injectable delivery

Discontinuation rates undermined the value argument Cost alone might not have tipped the scales

These symptoms usually occur during the first few weeks of treatment and may decrease

* After subcutaneous administration

J Neurosci Res (2021) 99(4):112035

JAMA 2018
